A Glimpse in the Future of Malignant Mesothelioma Treatment
Malignant mesothelioma (MMe) is a rare neoplasm with few therapeutic options available. The landscape of effective therapy for this disease remained unchanged in the last two decades. Recently, however, the introduction of Immune Checkpoint Inhibitors (ICIs) led to small, but nevertheless, promising...
Saved in:
Main Authors: | Gaetano Pezzicoli (Author), Mimma Rizzo (Author), Martina Perrone (Author), Silvia Minei (Author), Luciano Mutti (Author), Camillo Porta (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The therapeutic potential of the novel ribonuclease ranpirnase (Onconase®) in the treatment of malignant mesothelioma
by: Luciano Mutti, et al.
Published: (2011) -
The therapeutic potential of the novel ribonuclease ranpirnase (Onconase®) in the treatment of malignant mesothelioma
by: Luciano Mutti, et al.
Published: (2011) -
Breaking through the treatment desert of conventional mesothelin-targeted CAR-T cell therapy for malignant mesothelioma: A glimpse into the future
by: Yuning Wang, et al.
Published: (2024) -
Oncology Reviews: reasons for a new oncology journal
by: Camillo Porta
Published: (2011) -
Oncology Reviews: reasons for a new oncology journal
by: Camillo Porta
Published: (2011)